Zak Mir highlights some of the covid-19 players on the small-cap London market and gives an overview in this video charting update.
Top Twenty, The Stocks of the Year For 2021 – Review
A couple of weeks ago I compiled the ShareTalk Top 20 Stocks Of The Year 2020. It has been a tough year emotionally and otherwise for most of us. This
Share Talk Bulletin Board Heroes, Wednesday 20th January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Tiziana Life Sciences plc (TILS.Nasdaq.L) AIM Delisting and Admission to Main Market
AIM Delisting and Admission to the Standard Listing Segment of Main Market
Top Twenty, The Stocks of the Year For 2021 – Review
A couple of weeks ago I compiled the ShareTalk Top 20 Stocks Of The Year 2020. It has been a tough year emotionally and otherwise for most of us.
Share Talk Bulletin Board Heroes, Wednesday 13th January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Tiziana Life Sci Plc (TILS.L) Appointment of Chief Medical Officer
Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer
Share Talk Bulletin Board Heroes, Tuesday 12th January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Tiziana Life Sci PLC (TILS.L) to Present at Biotech Showcase Digital 2021
NEW YORK and LONDON – 11 January 2021 (GLOBE NEWSWIRE) – Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative
Top Twenty, The Stocks of the Year For 2021 – Review
A couple of weeks ago I compiled the ShareTalk Top 20 Stocks Of The Year 2020. It has been a tough year emotionally and otherwise for most of us.
Share Talk Bulletin Board Heroes, Wednesday 6th January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Tiziana Life Sci PLC (TILS.L) Completion of Foralumab Clinical Trial in Brazil
Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil